|
ISIN No
|
INE044A01036
|
BSE Code / NSE Code
|
524715 / SUNPHARMA
|
Book Value (Rs.)
|
233.38
|
Face Value
|
1.00
|
|
Bookclosure
|
28/07/2023
|
52Week High
|
1258
|
EPS
|
35.32
|
P/E
|
35.16
|
|
Market Cap.
|
297901.43 Cr.
|
52Week Low
|
922
|
P/BV / Div Yield (%)
|
5.32 / 0.93
|
Market Lot
|
1.00
|
|
Security Type
|
Other
|
|
You can view latest Board of Directors and Key Executives of the company.
Board of Directors
| Sr.No. | Name | Designation |
|
1
| Mr. Dilip S Shanghvi | Managing Director |
|
2
| Mr. Sailesh T Desai | Whole Time Director |
|
3
| Mr. Sudhir V Valia | Non Exe.Non Ind.Director |
|
4
| Dr. Pawan Goenka | Independent Director |
|
5
| Mr. Rama Bijapurkar | Independent Director |
|
6
| Mr. Gautam Doshi | Independent Director |
|
7
| Mr. Aalok D Shanghvi | Whole Time Director |
|
8
| Mr. Sanjay Asher | Independent Director |
|
Key Executives
| Sr.No. | Name | Designation |
|
1
| Mr. C S Muralidharan | Chief Financial Officer |
|
2
| Mr. Abhay Gandhi | CEO - North America |
|
3
| Dr. Uday Baldota | CEO - Taro Pharmaceutical Industries Ltd. |
|
4
| Dr.(Mrs.) Sapna Purohit | Senior Vice President & Head - HR |
|
5
| Dr. Azadar H Khan | Senior Vice President |
|
6
| Mr. Aalok Shanghvi | Executive Vice President |
|
7
| Mr. Anil Rao | Sr. Vice President & CIO |
|
8
| Mr. Kirti Ganorkar | CEO - India Business |
|